Asia Pacific Nuclear Medicine Radioisotopes Market – Growth & Forecast (2024 – 2032)

Published : 30 Aug 2024

Report Type : Regional

Share This On

Download Free Sample Now Buy This Report

Home > Reports > Pharmaceuticals > Healthcare > Asia Pacific Nuclear Medicine Radioisotopes Market – Growth & Forecast (2024 – 2032)

Description Table of Contents Scope of the Report

Asia Pacific Nuclear Medicine Radioisotopes Market - Size

Study Period

2018 - 2030

Base Year For Estimation

2023

Forecast Data Period

2024-2030

Historical Data Period

2018-2021

CAGR

7 %

Source: Envision Intelligence Analysis & Experts Insights.

*Graph shown for illustrative purpose only, the final report will have the graph with actual data and data labels

Nuclear medicine uses radiation to provide information about the functioning of a person’s specific organs or to treat disease. In most cases, the information is used by physicians to make a quick diagnosis of the patient’s illness. The thyroid, bones, heart, liver, and many other organs can be easily imaged, and disorders in their function revealed.

Asia-Pacific Nuclear Medicine Radioisotopes Market Segments Size & Growth:

Asia-Pacific nuclear medicine radioisotopes market is projected to reach approximately $XX billion by the end of 2024 with aCAGR of close to 11.55% from $XX billion in 2017 during the forecast timeline 2018-2024. Key parameters promoting the market growth include growing patient awareness, increasing SPECT and PET applications, development of better instruments and rising incidences of cancer and cardiac disorders. However, Reimbursement Problems and Strict Regulatory Issues are thereby hampering the market growth.

Asia-Pacific Nuclear Medicine Radioisotopes Market Segments Share:

Asia-Pacific nuclear medicine radioisotopes market is categorised into a type of radioisotopes which comprise of Iridium, Palladium, Iodine, Technetium, Cesium, and Others.Among them, Technetium holds the most significant share in the market. By Applications, the market is

Asia Pacific Nuclear Medicine Radioisotopes Market - Growth

Source: Envision Intelligence Analysis & Experts Insights.

*Graph shown for illustrative purpose only, the final report will have the graph with actual data and data labels

segmented into Neurology, Thyroid, Lymphoma, and Others.On the basis of Geography, India and China are projected to dominate the market with the most significant share and the growth in the Asia-Pacific economies is mainly attributed because of huge profit margins and growth prospects.

Asia-Pacific Nuclear Medicine Radioisotopes Market Trends:

Nuclear medicine has grown because of advances in technology, including hybrid imaging, the introduction of new radiopharmaceuticals for diagnosis and therapy, and the development of molecular imaging based on the tracer principle, which is not based on radioisotopes. Uniform growth of the field will require cost-effectiveness data and evidence that nuclear medicine procedures affect patients’ outcomes. Nuclear medicine physicians and radiologists will need more training in anatomic and molecular imaging. New educational models are being developed to ensure that future physicians will be adequately prepared.
GE Healthcare has entered into a strategic, long-term partnership with Roche to develop and co-market digital clinical decision support solutions jointly. The partnership will initially focus on products that accelerate and improve individualised treatment options for cancer and critical care patients. The two companies are aiming

You can also purchase parts of this report. Do you want to check out a section wise price list

Asia Pacific Nuclear Medicine Radioisotopes Market - Porter's Five Force Analysis

Source: Envision Intelligence Analysis & Experts Insights.

*Graph shown for illustrative purpose only, the final report will have the graph with actual data and data labels

to develop an industry-first digital platform, using advanced analytics to provide workflow solutions and apps that support clinical decisions. This will allow the seamless integration and analysis of in-vivo and in-vitro data, patient records, medical best practice, real-time monitoring and the latest research outcomes.

Asia-Pacific Nuclear Medicine Radioisotopes Market Research Report:

An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.

To have complete market analysis, industry value chain analysis, Porter’s Five Force Analysis, PESTLE, SWOT analysis, and Y-o-Y analysis were carried to understand the market more comprehensively.

Regional diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year

Identifying DROC in the current market and their impact in altering the market dynamics.

Competitive landscape analysis to identify the mergers and acquisitions which will have a comparative financial study with significant competitors.

Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.

The primary market players, such as

Bracco Imaging S.P.A.
Cambridge Isotope Laboratories
Cardinal Health, Inc.
Covidien, Plc.
Eczacibasi-Monrol

Exclusive Benefits

Credibility and
Transparency

We actively recruit consumers, business professionals, and elusive individuals for our research panels, fostering enduring relationships. Our commitment to transparency is evident in the comprehensive listing of primary and secondary data sources, ensuring unwavering credibility in our reports.

Exhaustive
Coverage

Uncover the full spectrum with Envision Intelligence. Our detailed and extensive geographical coverage, coupled with survey consultation services, spans brand tracking, concept testing, and consumer behaviour analysis. Adapt to your evolving needs with scalable market research services that leave no facet unexplored.

Competitive
Edge

Stay ahead with Envision Intelligence. Our reports provide the latest market updates up to the date of purchase. Recognising the urgency of impactful decisions, we deliver timely analyses on the unprecedented choices made by CXOs during the COVID-19 crisis—providing valuable insights at no extra cost.

Golden
pportunities

Unearth hidden gems with Envision Intelligence. Our analysts and consultants conduct a comprehensive strategic sieve analysis, augmented by AI tools, to identify non-obvious, golden, and emerging opportunities. Evaluate possibilities that set you apart in the market.

Top-notch Reportsd
Guaranteed

Experience unparalleled depth with Envision Intelligence. Over 70% of our research is exclusive, establishing us as the premier source for in-depth and extensive market insights. Elevate your decision-making with reports that go beyond the ordinary.

Post Purchase
Support

Empower your journey with Envision Intelligence. Our commitment extends beyond the purchase. Enjoy post-purchase support for three months, with queries addressed within 24 business hours via telephone or email. We stand by you in your quest for ongoing success.